Document 0324
 DOCN  M9440324
 TI    Treatment of bacterial sexually transmitted diseases.
 DT    9404
 AU    Elsner P; Department of Dermatology, University of Zurich, Switzerland.
 SO    Semin Dermatol. 1993 Dec;12(4):342-51. Unique Identifier : AIDSLINE
       MED/94145868
 AB    Sexually transmitted diseases (STD) cause significant morbidity in the
       industrialized nations and, even more so in third world countries.
       Genital ulcerative STD such as herpes genitalis, syphilis, and chancroid
       have been identified as important risk factors for the spread of human
       immunodeficiency virus infection. Efficient and safe therapeutic regimen
       are therefore essential to cure the individual and to prevent spread of
       STD in the community. In this review, the current treatment guidelines
       for the bacterial STD gonorrhoea, chlamydial infections, syphilis, and
       chancroid are summarized and recent therapeutic developments are
       discussed.
 DE    Antibiotics/*THERAPEUTIC USE  Bacterial Infections/COMPLICATIONS/*DRUG
       THERAPY/EPIDEMIOLOGY/  MICROBIOLOGY  Cervicitis/DRUG
       THERAPY/MICROBIOLOGY  Chancroid/DRUG THERAPY/MICROBIOLOGY  Chlamydia
       trachomatis  Chlamydia Infections  Clinical Protocols  Drug Resistance,
       Microbial  Female  Gonorrhea/DRUG THERAPY/EPIDEMIOLOGY/MICROBIOLOGY
       Human  Male  Sexually Transmitted Diseases/*DRUG THERAPY/EPIDEMIOLOGY/
       MICROBIOLOGY  Syphilis/DRUG THERAPY/EPIDEMIOLOGY/MICROBIOLOGY
       Urethritis/DRUG THERAPY/MICROBIOLOGY  JOURNAL ARTICLE  REVIEW  REVIEW,
       MULTICASE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).